Molecular alterations and expression of succinate dehydrogenase complex in wild-type kit/pdgfra/braf gastrointestinal stromal tumors

European Journal of Human Genetics

Volumn 21, Issue 5, 2013, Pages 503-510

  Celestino, Ricardo ^a,b   Lima, Jorge ^a,b   Faustino, Alexandra ^a   Vinagre, Joao ^a,b   Maximo, Valdemar ^a,b   Gouveia, Antonio ^b,c   Soares, Paula ^a,b   Lopes, Jose Manuel ^a,b,c  

^a UNIVERSITY OF PORTO   (Portugal)

^b University of Porto   (Portugal)

^c HOSPITAL DE SÃO JOÃO   (Portugal)

Author keywords

Carney triad; Carney Stratakis dyad; Gastrointestinal stromal tumors; SDH

Indexed keywords

B RAF KINASE; IMATINIB; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; STEM CELL FACTOR RECEPTOR; SUCCINATE DEHYDROGENASE;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CHONDROMA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL STROMAL TUMOR; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PARAGANGLIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; WILD TYPE;

ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; BENZAMIDES; CHLORIDE CHANNELS; FEMALE; GASTROINTESTINAL STROMAL TUMORS; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASM PROTEINS; PARAGANGLIOMA; PIPERAZINES; PROTO-ONCOGENE PROTEINS B-RAF; PROTO-ONCOGENE PROTEINS C-KIT; PYRIMIDINES; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; SEQUENCE ANALYSIS, DNA; SUCCINATE DEHYDROGENASE;

EID: 84876668234     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2012.205     Document Type: Article

References (43)

1. Fletcher CD, Berman JJ, Corless C et al: Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol 2002; 33: 459-465. (Pubitemid 34747864)
2. Heinrich MC, Corless CL, Duensing A et al: PDGFRA activating mutations in gastrointestinal stromal tumors. Science 2003; 299: 708-710. (Pubitemid 36159485)
3. Hirota S, Isozaki K, Moriyama Y et al: Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998; 279: 577-580. (Pubitemid 28067289)
4. Lasota J, Miettinen M: KIT and PDGFRA mutations in gastrointestinal stromal tumors (GISTs). Semin Diagn Pathol 2006; 23: 91-102. (Pubitemid 44692417)
5. Choi YR, Kim H, Kang HJ et al: Overexpression of high mobility group box 1 in gastrointestinal stromal tumors with KIT mutation. Cancer Res 2003; 63: 2188-2193. (Pubitemid 36538625)
6. Kim NG, Kim JJ, Ahn JY et al: Putative chromosomal deletions on 9P, 9Q and 22Q occur preferentially in malignant gastrointestinal stromal tumors. Int J Cancer 2000; 85: 633-638. (Pubitemid 30080474)
7. Lasota J, Jasinski M, Sarlomo-Rikala M, Miettinen M: Mutations in exon 11 of c-Kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas. Am J Pathol 1999; 154: 53-60. (Pubitemid 29031611)
8. Lux ML, Rubin BP, Biase TL et al: KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors. Am J Pathol 2000; 156: 791-795. (Pubitemid 30626936)
9. Rubin BP, Singer S, Tsao C et al: KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. Cancer Res 2001; 61: 8118-8121. (Pubitemid 33091601)
10. Taniguchi M, Nishida T, Hirota S et al: Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors. Cancer Res 1999; 59: 4297-4300. (Pubitemid 29418746)
11. Rubin BP, Heinrich MC, Corless CL: Gastrointestinal stromal tumour. Lancet 2007; 369: 1731-1741. (Pubitemid 46778870)
12. Lasota J, Miettinen M: Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours. Histopathology 2008; 53: 245-266.
13. Demetri GD, von Mehren M, Blanke CD et al: Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 2002; 347: 472-480. (Pubitemid 34879334)
14. Heinrich MC, Owzar K, Corless CL et al: Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group. J Clin Oncol 2008; 26: 5360-5367.
15. Janeway KA, Albritton KH, Van Den Abbeele AD et al: Sunitinib treatment in pediatric patients with advanced GIST following failure of imatinib. Pediatr Blood Cancer 2009; 52: 767-771.
16. Demetri GD, van Oosterom AT, Garrett CR et al: Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial. Lancet 2006; 368: 1329-1338. (Pubitemid 44528723)
17. Agaimy A, Terracciano LM, Dirnhofer S et al: V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wild-type gastrointestinal stromal tumours. J Clin Pathol 2009; 62: 613-616.
18. Agaram NP, Wong GC, Guo T et al: Novel V600E BRAF mutations in imatinib-naive and imatinib-resistant gastrointestinal stromal tumors. Genes Chromosomes Cancer 2008; 47: 853-859.
19. Martinho O, Gouveia A, Viana-Pereira M et al: Low frequency of MAP kinase pathway alterations in KIT and PDGFRA wild-type GISTs. Histopathology 2009; 55: 53-62.
20. Agaimy A, Markl B, Arnholdt H et al: Multiple sporadic gastrointestinal stromal tumours arising at different gastrointestinal sites: pattern of involvement of the muscularis propria as a clue to independent primary GISTs. Virchows Arch 2009; 455: 101-108.
21. Celestino R, Lima J, Faustino A et al: A novel germline SDHB mutation in a gastrointestinal stromal tumor patient without bona fide features of the Carney- Stratakis dyad. Fam Cancer 2012; 11: 189-194.
22. Gaal J, Stratakis CA, Carney JA et al: SDHB immunohistochemistry: a useful tool in the diagnosis of Carney-Stratakis and Carney triad gastrointestinal stromal tumors. Mod Pathol 2011; 24: 147-151.
23. Gill AJ, Chou A, Vilain R et al: Immunohistochemistry for SDHB divides gastrointestinal stromal tumors (GISTs) into 2 distinct types. Am J Surg Pathol 2010; 34: 636-644.
24. Janeway KA, Kim SY, Lodish M et al: Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations. Proc Natl Acad Sci USA 2011; 108: 314-318.
25. McWhinney SR, Pasini B, Stratakis CA: Familial gastrointestinal stromal tumors and germ-line mutations. N Engl J Med 2007; 357: 1054-1056. (Pubitemid 47367102)
26. Miettinen M, Wang ZF, Sarlomo-Rikala M, Osuch C, Rutkowski P, Lasota J: Succinate dehydrogenase-deficient GISTs: a clinicopathologic, immunohistochemical, and molecular genetic study of 66 gastric GISTs with predilection to young age. Am J Surg Pathol 2011; 35: 1712-1721.
27. Pasini B, McWhinney SR, Bei T et al: Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD. Eur J Hum Genet 2008; 16: 79-88. (Pubitemid 350284184)
28. Carney JA, Stratakis CA: Familial paraganglioma and gastric stromal sarcoma: a new syndrome distinct from the Carney triad. Am J Med Genet 2002; 108: 132-139.
29. Daum O, Vanecek T, Sima R, Michal M: Gastrointestinal stromal tumor: update. Klinicka Onkologie 2006; 19: 203-211. (Pubitemid 44757552)
30. Carney JA: Gastric stromal sarcoma, pulmonary chondroma, and extra-adrenal paraganglioma (Carney Triad): natural history, adrenocortical component, and possible familial occurrence. Mayo Clin Proc 1999; 74: 543-552.
31. Matyakhina L, Bei TA, McWhinney SR et al: Genetics of carney triad: recurrent losses at chromosome 1 but lack of germline mutations in genes associated with paragangliomas and gastrointestinal stromal tumors. J Clin Endocrinol Metab 2007; 92: 2938-2943. (Pubitemid 47236353)
32. Stratakis CA, Carney JA: The triad of paragangliomas, gastric stromal tumours and pulmonary chondromas (Carney triad), and the dyad of paragangliomas and gastric stromal sarcomas (Carney-Stratakis syndrome): molecular genetics and clinical implications. J Intern Med 2009; 266: 43-52.
33. Gomes AL, Gouveia A, Capelinha AF et al: Molecular alterations of KIT and PDGFRA in GISTs: evaluation of a Portuguese series. J Clin Pathol 2008; 61: 203-208. (Pubitemid 351218881)
34. Miettinen M, Lasota J: Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol 2006; 23: 70-83. (Pubitemid 44692418)
35. Cascon A, Montero-Conde C, Ruiz-Llorente S et al: Gross SDHB deletions in patients with paraganglioma detected by multiplex PCR: a possible hot spot? Genes Chromosomes Cancer 2006; 45: 213-219. (Pubitemid 43238472)
36. Lima J, Feijao T, Ferreira da Silva A et al: High frequency of germline succinate dehydrogenase mutations in sporadic cervical paragangliomas in northern Spain: mitochondrial succinate dehydrogenase structure-function relationships and clinicalpathological correlations. J Clin Endocrinol Metab 2007; 92: 4853-4864. (Pubitemid 350223469)
37. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
38. Burnichon N, Briere JJ, Libe R et al: SDHA is a tumor suppressor gene causing paraganglioma. Hum Mol Genet 2010; 19: 3011-3020.
39. Carney JA, Sheps SG, Go VL, Gordon H: The triad of gastric leiomyosarcoma, functioning extra-adrenal paraganglioma and pulmonary chondroma. N Engl J Med 1977; 296: 1517-1518. (Pubitemid 8140566)
40. Pantaleo MA, Nannini M, Astolfi A, Biasco G: A distinct pediatric-type gastrointestinal stromal tumor in adults: potential role of succinate dehydrogenase subunit A mutations. Am J Surg Pathol 2011; 35: 1750-1752.
41. Doyle LA, Nelson D, Heinrich MC, Corless CL, Hornick JL: Loss of sdhb expression is limited to a distinctive subset of gastric wild-type gastrointestinal stromal tumors: a comprehensive genotype-phenotype correlation study. Histopathology 2012 no-no.
42. Rege TA, Wagner AJ, Corless CL, Heinrich MC, Hornick JL: 'Pediatric-type' gastrointestinal stromal tumors in adults: distinctive histology predicts genotype and clinical behavior. Am J Surg Pathol 2011; 35: 495-504.
43. West RB, Corless CL, Chen X et al: The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status. Am J Pathol 2004; 165: 107-113. (Pubitemid 38821818)